134 results on '"Krishnarajah, G"'
Search Results
2. Modeling Respiratory Syncytial Virus Adult Vaccination in the United States With a Dynamic Transmission Model.
3. Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to egg-based trivalent high dose and other egg-based vaccines
4. Adherence to rotavirus vaccination quality measures in a commercially insured population
5. PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY
6. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
7. Drug titration patterns and HbA1c levels in type 2 diabetes
8. Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy
9. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
10. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study
11. Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis
12. Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study
13. P156 Use of rescue medication in hereditary angioedema attacks and its relation to attack severity
14. P160 Indirect comparison of placebo-controlled trials of C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks
15. P158 Physician perspectives on long-term prophylaxis of hereditary angioedema: a pragmatic review
16. P159 Attacks avoided and cost offsets associated with subcutaneous C1-inhibitor (human) long-term prophylaxis of hereditary angioedema
17. COST OF DIAGNOSED HERPES ZOSTER COMPLICATIONS IN PATIENTS AGE ≥50 YEARS: A U.S. CLAIMS DATA ANALYSIS
18. Experience of hypoglycaemic symptoms is associated with lower quality of life (EuroQoL) among patients with type 2 diabetes on oral antihyperglycaemic therapy in Europe
19. Vaccine Timeliness: A Cost Analysis of the Implications of Delayed Vaccination
20. Drug titration patterns and HbA 1c levels in type 2 diabetes.
21. PDB44 A SYSTEMATIC REVIEW OF ADHERENCE, QUALITY OF LIFE AND MEDICAL COSTS IN FIXED-DOSE COMBINATION REGIMENS IN DIABETES
22. PDB70 EVALUATION OF SITAGLIPTIN DOSING AMONG RENAL IMPAIRED TYPE 2 DIABETES MELLITUS PATIENTS
23. PDB53 IMPACT OF HYPOGLYCAEMIA ON PATIENT REPORTED OUTCOMES: A SYSTEMATIC LITERATURE REVIEW
24. Drug titration patterns and HbA1clevels in type 2 diabetes
25. PDB17 GLYCEMIC VARIABILITY AND COMPLICATIONS IN PATIENTS WITH DIABETES MELLITUS: EVIDENCE FROM A SYSTEMATIC REVIEW OF THE LITERATURE
26. PDB38 THE EFFECT OF WEIGHT CHANGES ON HEALTH-RELATED QUALITY OF LIFE AND WORK IMPAIRMENT IN PATIENTS WITH TYPE 2 DIABETES
27. PDB61 HEALTH CARE COSTS AND UTILIZATION ASSOCIATED WITH TREATMENT MODIFICATION IN TYPE-2 DIABETES MELLITUS (T2DM) PATIENTS TAKING ORAL ANTI-DIABETIC DRUGS (OADS)
28. Total health care expenditures associated with treatment modification in type 2 diabetes mellitus (T2DM) patients taking oral anti-diabetic drugs (OAdDS)
29. PDB76 TREATMENT SATISFACTION IS POSITIVELY ASSOCIATED WITH GLYCEMIC CONTROLAND NEGATIVELY ASSOCIATED WITH PATIENT REPORTED EXPERIENCE OF HYPOGLYCEMIC SYMPTOMS AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM) ON ORAL ANTI-HYPERGLYCEMIC AGENTS (OHA) IN EUROPE
30. PDB52 FACTORS ASSOCIATED WITH THE CHOICE OF A GLITAZONES OR SULFONYLUREA AS ADD ON TO ONGOING METFORMIN MONOTHERAPY
31. PDB1 GLYCEMIC CONTROL GOAL ATTAINMENT AMONGTYPE 2 DIABETIC PATIENTSWHO INITIATED ORAL COMBINATION THERAPY IN HUNGARY
32. DB4 TREATMENT ADHERENCE AND BARRIERS TO ADHERENCE ARE ASSOCIATED WITH GLYCEMIC CONTROL AND EXPERIENCE OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM) ON ORAL ANTI-HYPERGLYCEMIC AGENTS (OHA) IN EUROPE
33. DB1 IMPACT OF ROSIGLITAZONETHERAPY ONTHE LIPID PROFILE AND LIPID-LOWERINGTREATMENT IN TYPE 2 DIABETES PATIENTS
34. PIN33 - Vaccine Timeliness: A Cost Analysis of the Implications of Delayed Vaccination
35. Drug titration patterns and HbA1c levels in type 2 diabetes.
36. PIN33 Vaccine Timeliness: A Cost Analysis of the Implications of Delayed Vaccination
37. Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
38. Respiratory Syncytial Virus-Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States.
39. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
40. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States.
41. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
42. Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season.
43. Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.
44. Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy.
45. Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks.
46. Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.
47. The economic burden of CIDP in the United States: A case-control study.
48. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis.
49. Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children.
50. Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.